Gulf Times - CanSino-Biologics
CanSinoBIO's inhaled Covid vaccine candidate triggers immune response-early trial

CanSinoBIO's inhaled Covid vaccine candidate triggers immune response-early trial

An inhaled version of CanSino BioLogics' (CanSinoBIO) Covid-19 vaccine triggered immune responses without serious side effects, an early-stage clinical trial showed.

Desperately seeking a Covid-19 vaccine - the race is on

Desperately seeking a Covid-19 vaccine - the race is on

Seven months after the emergence of the worst global health crisis in a century the race is on to find the medical equivalent of the Holy Grail -- a Covid-19 vaccine.

China's CanSino in talks for Covid vaccine Phase III trial overseas

China's CanSino in talks for Covid vaccine Phase III trial overseas

Chinese vaccine developer CanSino Biologics is in talks with Russia, Brazil, Chile and Saudi Arabia to launch a Phase III trial of its experimental Covid-19 vaccine, its co-founder said on Saturday.